background_placeholder
Clinical Cancer Research

Articles about Clinical Cancer Research

     
Kies meer

Trending
Er zijn @count nieuwe artikelen
Tuesday, February 15, 2022 - 03:32 - In Trending
Targeting the ubiquitin-proteasome system using the UBA1 inhibitor TAK-243 is a potential therapeutic strategy for small cell lung cancer
Tuesday, February 15, 2022 - 03:32 - In Trending
Praluzatamab ravtansine, a CD166-targeting antibody-drug conjugate, in patients with advanced solid tumors: an open-label phase 1/2 trial
Tuesday, February 15, 2022 - 03:32 - In Trending
ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma
Tuesday, February 15, 2022 - 03:32 - In Trending
Tumor drug concentration and phosphoproteomic profiles after two weeks of treatment with sunitinib in patients with newly-diagnosed glioblastoma
Friday, February 11, 2022 - 03:32 - In Trending
Breast Cancer Index is a predictive biomarker of treatment benefit and outcome from extended tamoxifen therapy: final analysis of the Trans-aTTom study
Thursday, February 10, 2022 - 03:32 - In Trending
Disruption of DNA Repair and Survival Pathways through Heat Shock Protein inhibition by Onalespib to Sensitize Malignant Gliomas to Chemoradiation therapy
Thursday, February 10, 2022 - 03:32 - In Wetenschap
Bias Reduction through Analysis of Competing Events (BRACE) Correction to Address Cancer Treatment Selection Bias in Observational Data
Thursday, February 10, 2022 - 03:32 - In Wetenschap
Post-transplant malignancies show reduced T-cell abundance and tertiary lymphoid structures as correlates of impaired cancer immunosurveillance.
Thursday, February 10, 2022 - 03:32 - In Trending
Telaglenastat Plus Cabozantinib or Everolimus For Advanced or Metastatic Renal Cell Carcinoma: an Open-Label Phase 1 Trial
Wednesday, February 9, 2022 - 03:32 - In Trending
DOT1L is a novel cancer stem cell target for triple negative breast cancer

Kies uw tags

NSCLC
SCLC
breast cancer
triple negative breast cancer
her2
HER2-Positive
thyroid cancer
to
neuroendocrine tumor
colorectal cancer
bowel cancer
rectal cancer
gastric cancer
cholangiocarcinoma
ovarian cancer
cervical cancer
endometrial cancer
endometrial carcinoma
ovarian tumor
oropharyn
DCIS
ductal carcinoma
hepatocellular carcinoma
CRC
colorectal cancers
mCRC
biliary tract cancer
liver cancer
lymphoma
multiple myeloma
diffuse large b-cell lymphoma
leukemia
myelodysplastic syndrome
leukaemia
non-hodgkin
acute myeloid leukemia
AML
hematological malignancies
lung cancer
small cell lung cancer
non-small cell lung cancer
mesothelioma
pleural mesothelioma
glioma
astrocytoma
medulloblastoma
hodgkin
hodgkin lymphoma
pediatric cancer
retinoblastoma
meningioma
sarcoma
CLL
follicular lymphoma
Osteosarcoma
Angiosarcoma
Rhabdomyosarcoma
Ple
schwannoma
Gastrointestinal stromal tumor
skin cancer
melanoma
basal cell carcinoma
Malignant peripheral nerve sheath tumor
lung carcinoma
urothelial carcinoma
prostate cancer
kidney cancer
bladder cancer
chronic myeloid leukemia
ewing sarcoma
Leiomyosarcoma
Liposarcoma
neuroblastoma
renal cell carcinoma
CML
testicular cancer
RCC
kaposi sarcoma
CRPC
carcinoid
polycythemia vera
Chondrosarcoma
lobular carcinoma
neuroendocrine neoplasm
thyroid carcinoma
ovarian carcinoma
mantle cell lymphoma
prostate carcinoma
neuro-oncology
pNET
colorectal carcinoma
MPN
Fibrosarcoma
ER-positive
Desmoplastic small round cell tumor
pediatric brain tumor
neuroendocrine carcinoma
NHL
Alveolar soft part sarcoma
eye cancer
merkel cell carcinoma
pheochromocytoma